Report Overview
The human microbiome market will grow at a CAGR of 20.42% to reach US$2.38 billion in 2030 from US$0.94 billion in 2025.
Major factors driving the global human microbiome market growth are increasing instances of lifestyle diseases, diarrheal infections, predominant changes in the lifestyle of the global population, and an increase in the aged population and its applications in healthcare. Moreover, technological enhancements in biomedical sciences and growing research investment in technology and product sectors is also positively impacting the market growth positively. However, lack of awareness about the use and advantages of prebiotics and probiotics and government restrictions on their usage are major challenges for the market players.
The global human microbiome market report provides a detailed analysis of the industry landscape, offering strategic and executive-level insights supported by data-driven forecasts and analysis. This regularly updated report equips decision-makers with actionable intelligence on current market trends, emerging opportunities, and competitive dynamics. It explores consumer demand across various regions and product types, such as therapeutics, diagnostics, and probiotics, while also examining purchasing behaviours and key customer segments. Additionally, the report delves into technological advancements, key government policies, regulation.
Human Microbiome Market Scope:
| Report Metric | Details |
|---|---|
| Total Market Size in 2025 | USD 0.94 billion |
| Total Market Size in 2030 | USD 2.38 billion |
| Forecast Unit | Billion |
| Growth Rate | 20.42% |
| Study Period | 2020 to 2030 |
| Historical Data | 2020 to 2023 |
| Base Year | 2024 |
| Forecast Period | 2025 – 2030 |
| Segmentation | Product, Disease, Application, Geography |
| Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| Companies |
|
Market Segmentation
By Product
By Disease
By Application
By Geography
Table of Contents
1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL HUMAN MICROBIOME MARKET BY PRODUCT
5.1. Introduction
5.2. Probiotics
5.3. Prebiotics
5.4. Supplements
5.5. Others
6. GLOBAL HUMAN MICROBIOME MARKET BY DISEASE
6.1. Introduction
6.2. Diabetes
6.3. Autoimmune Disorder
6.4. Cancer
6.5. Obesity
6.6. Others
7. GLOBAL HUMAN MICROBIOME MARKET BY APPLICATION
7.1. Introduction
7.2. Diagnostics
7.3. Therapeutics
8. GLOBAL HUMAN MICROBIOME MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Italy
8.4.6. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Thailand
8.6.6. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Seres Therapeutics
10.2. Microbiome Therapeutics Innovation Group
10.3. Vedanta Biosciences Inc.
10.4. Metabiomics
10.5. Ferring Pharmaceuticals
10.6. Finch Therapeutics
10.7. BiomeBank
10.8. Biohm Technologies
10.9. Resbiotic
10.10. Immuron Limited
10.11. Maat Pharma
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES
Global Human Microbiome Market Report
Trusted by the world's leading organizations
